 |
|
|
|
|
08.00 – 19.30 |
Registration open |
|
|
08.00 – 09.00 |
Posters |
|
Hall Agora 2 |
| |
|
|
|
|
09.00 – 10.00
|
Symposium 5
Oestrogen Chair: J. Compston (Cambridge, UK),
H. van Leeuwen (Rotterdam, Netherlands)
|
|
Athena Theatre
|
| I022 |
|
Estrogens, androgens and the regulation of bone remodeling |
|
R. Baron (New Haven, USA) |
| I023 |
|
Clinical role for estrogen replacement and SERMS after
Women's Health Initiative |
|
J. Stevenson (London, UK) |
| |
|
|
|
|
10.00 – 11.00
|
Oral Presentations 7
Hormones Chair: J. Compston (Cambridge, UK),
H. van Leeuwen (Rotterdam, Netherlands)
|
|
Athena Theatre
|
| OP031 |
|
Gene therapy with growth hormone alone normalizes bone
mass and bone structure in hypophysectomized MICE
ECTS Young Investigator Award |
|
N. Ditzel (Odense, Denmark) |
| OP032 |
|
DLK1/PREF-1 (EGF-like homeotic protein) inhibits gene
expression of insulin-like growth factor (IGF) - binding proteins during
osteoblast differentiation of human bone marrow stromal cells |
|
B. Abdallah (Odense, Denmark) |
| OP033 |
|
Ghrelin is expressed in human bone cells and enhances
the proliferation of osteoblasts |
|
B. Van der Eerden (Rotterdam, Netherlands) |
| OP034 |
|
Novel insights into the mechanism of action of vitamin
D metabolites in bone: evidence for 1,25-dihydroxyvitamin D3 synthesis
by osteoblasts and direct stimulation of mineralization
ECTS Young Investigator Award |
|
M. Van Driel (Rotterdam, Netherlands) |
| OP035 |
|
An upstream region of mouse osteoprotegerin binds estrogen
receptor and contributes to estrogen responsiveness |
|
M. Rumpler (Vienna, Austria) |
| |
|
|
|
|
11.00 – 12.45 |
Coffee and Posters |
|
Hall Agora 2 |
12.00 – 12.45 |
Lunch |
|
|
| |
|
|
|
|
12.45 – 14.00
|
Workshop 5
Biomineralization Chair: G. Boivin (Lyon, France),
S Ralston (Aberdeen, UK)
|
|
Athena Theatre
|
| I024 |
|
Analysis of bone mineral by qBEI |
|
P. Roschger (Vienna, Austria) |
| I025 |
|
Vibrational spectroscopic characterization of bone
mineral and collagen cross-links |
|
A. Boskey (New York, USA) |
| I026 |
|
Microscopy for mineralised tissues in bones |
|
A. Boyde (London, UK) |
| |
|
|
|
|
12.45 – 14.00 |
Workshop 6
Case Presentations
Chair: R. Civitelli (St Louis) |
|
Hermès Theatre
|
| |
|
A case of tumour induced osteomalacia; diagnosis and
response to treatment |
|
M. Davie (Oswestry, UK) |
| |
|
Primary hypoparathyroidism resistant to conventional
therapy |
|
J. Gallacher (Glasgow, UK) |
| |
|
A young women with headache and skull abnormalities:
a long road to a simple diagnosis |
|
M. C. Zillikens & H. A. P. Pols (Rotterdam, Netherlands) |
| |
|
|
|
|
14.00 – 15.00
|
Symposium 6
Genetics of Osteoporosis Chair: G. Carle (Nice, France),
A. Uitterlinden (Rotterdam, Netherlands)
|
|
Athena Theatre
|
| I027 |
|
Progress in detecting osteoporosis susceptibility genes |
|
T. Spector (London, UK) |
| I028 |
|
Quantitating the effects of polygenes by meta-analysis |
|
J. Ioannidis (Ioannina, Greece) |
| |
|
|
|
|
15.00 – 16.00
|
Oral Presentations 8
Genetics Chair: G. Carle (Nice, France),
A. Uitterlinden (Rotterdam, Netherlands)
|
|
Athena Theatre
|
| OP036 |
|
Loci for regulation of BMD in men and women: the Famos
study |
|
S. Ralston (Aberdeen, UK) |
| OP037 |
|
Ethnic variation in haplotype structure of the complete
VDR gene and association with fracture risk
ECTS Young Investigator Award
|
|
Yue Fang (Rotterdam, Netherlands) |
| OP038 |
|
Polymorphisms of oestrogen receptor alpha predict bone
loss in perimenopausal women
ECTS Young Investigator Award |
|
U. Pettersson (Aberdeen, UK)
|
| OP039 |
|
Gene interaction between estrogen receptor alpha and
IGF-I determines hip bone strength in elderly men |
|
F. Rivadeneira (Rotterdam, Netherlands) |
| OP040 |
|
LDL-receptor related protein 5 gene polymorphisms influence
the normal variation of bone mineral density |
|
A. Koay (Oxford, UK) |
| |
|
|
|
|
16.00 – 16.30 |
|
Coffee Break |
|
|
| |
|
|
|
|
16.30 – 17.30
|
Oral Presentations 9
PTH Chair: C. Silve (Paris, France),
J. Reeve (Cambridge, UK)
|
|
Athena Theatre
|
| OP041 |
|
Resistance to the bone anabolic effect of PTH(1-34)
on an isocaloric low protein diet |
|
P. Ammann (Geneva, Switzerland) |
| OP042 |
|
Arrestins regulate bone remodeling induced by ovariectomy
and intermittent PTH treatment |
|
S. L. Ferrari (Geneva, Switzerland)
|
| OP043 |
|
Role of osteoblastic matrix metalloproteinases (MMP’s)
on the anabolic action of parathyroid hormone in vivo |
|
V. Geoffroy (Paris, France)
|
| OP044 |
|
Anabolic actions of PTH are associated with an early
inhibition of mineralization in vivo
ECTS Young Investigator Award |
|
G. Pettway (Ann Arbor, USA) |
| OP045 |
|
High-impact exercise and bone mineral density in randomly
selected population of premenopausal women
ECTS Young Investigator Award |
|
A. Vainionpää (Oulu, Finland) |
| |
|
|
|
|
17.30 – 19.30 |
Satellite Symposium
Achieving the Goal of Osteoporosis
Therapy; Fracture Reduction
Supported by Merck Sharp & Dohme
|
|
Hermès Theatre |
| |
|
|
|
|
20.30 |
Gala Dinner |
|
Restaurant Les Pêcheurs,
Juan Les Pins
|
